Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits-Reference-Cited by-同舟云学术

Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits

Published:2013-09 Issue:3 Volume:311 Page:191-204
ISSN:0300-483X
Container-title:Toxicology
language:en
Short-container-title:Toxicology

Author:

Jirkovský Eduard,Lenčová-Popelová Olga,Hroch Miloš,Adamcová Michaela,Mazurová Yvona,Vávrová Jaroslava,Mičuda Stanislav,Šimůnek Tomáš,Geršl Vladimír,Štěrba Martin

Funder

Czech Science Foundation

Charles University research program PRVOUK

Publisher

Elsevier BV

Subject

Toxicology

Reference54 articles.

1. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper;Aapro;Ann. Oncol.,2011

2. Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity;Adamcova;Expert Opin. Drug Saf.,2005

3. Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane;Barry;J. Clin. Oncol.,2008

4. Anthracycline cardiomyopathy monitored by morphologic changes;Billingham;Cancer Treat. Rep.,1978

5. Dexrazoxane: a review of its use for cardioprotection during anthracycline chemotherapy;Cvetkovic;Drugs,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron metabolism in doxorubicin-induced cardiotoxicity: From mechanisms to therapies;The International Journal of Biochemistry & Cell Biology;2024-09

2. Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review;Current Treatment Options in Oncology;2024-07-27

3. Molecular Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity;JACC: Basic to Translational Science;2024-06

4. Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage;Toxicological Sciences;2024-01-30

5. Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model;Frontiers in Pharmacology;2024-01-03